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Targeted Disruption of the MyD88 Gene Results
in Loss of IL-1- and IL-18-Mediated Function
et al., 1998). Despite the functional similarity, IL-18 is
not structurally related to IL-12. IL-18 has a structural
similarity with IL-1 (Bazan et al., 1996). IL-18 is synthe-
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to that of IL-1R (Gay and Keith, 1991). The signaling
pathway through Toll in Drosophila shows striking struc-
tural and functional similarities with the signaling path-Summary
way induced by the IL-1Rs in mammals (Wasserman,
1993; Belvin and Anderson, 1996). Toll activates theMyD88, originally isolated as a myeloid differentiation
transcription factor Dorsal, a Drosophila homolog of NF-primary response gene, is shown to act as an adaptor
kB, upon binding to its ligand Spatzle (Morisato andin interleukin-1 (IL-1) signaling by interacting with both
Anderson, 1994, 1995). Transduction of the intracellularthe IL-1 receptor complex and IL-1 receptor±asso-
signal generated by Toll requires the adaptor moleculeciated kinase (IRAK). Mice generated by gene tar-
called Tube for the association of Toll with the Pellegeting to lack MyD88 have defects in T cell prolifera-
protein kinase, a Drosophila homolog of IRAK (Letsoution as well as induction of acute phase proteins and
et al., 1993; Shelton and Wasserman, 1993; Grosshanscytokines in response to IL-1. Increases in interferon-g
et al., 1994; Galindo et al., 1995; Norris and Manley,production and natural killer cell activity in response
1996). Until recently, a mammalian homolog of Tube hadto IL-18 are abrogated. In vivo Th1 response is also
not been identified.impaired. Furthermore, IL-18-induced activation of
MyD88 was originally isolatedas a myeloid differentia-NF-kB and c-Jun N-terminal kinase (JNK) is blocked in
tion primary response gene, which is rapidly inducedMyD882/2 Th1-developing cells. Taken together, these
upon IL-6-stimulated differentiation to macrophages inresults demonstrate that MyD88 is a critical compo-
M1 myeloleukemic cells (Lord et al., 1990). This immedi-nent in the signaling cascade that is mediated by IL-1
ate±early activation profile suggested that MyD88 func-receptor as well as IL-18 receptor.
tions in the regulated progression of myeloid differentia-
tion. MyD88 is subsequently found to be related to theIntroduction
IL-1R family, particularly Toll (Hultmark, 1994; Hardiman
et al., 1996; Bonnert et al., 1997). Different from the IL-Interleukin-1 (IL-1) is a proinflammatory cytokine in-
1R family, MyD88 does not harbor the transmembranevolved in local and systemic inflammatory reaction (re-
portion. The death domain is present in its N terminus.viewed by Dinarello, 1989, 1996). IL-1 induces a variety
The C-terminal domain of the protein is highly homolo-of inflammatory proteins, such as acute phase proteins,
gous to the cytoplasmic segments of the IL-1R family.cytokines, and adhesion molecules, whose genes are
Recently, MyD88 has been cloned as an adaptor mole-mainly regulated by NF-kB and/or AP-1 (reviewed by
cule that recruits IRAK to the IL-1R complex after IL-1Dinarello, 1989, 1996). IL-1 signaling is initiated by the
stimulation and activates NF-kB (Muzio et al., 1997;formation of the high-affinity complex composed of IL-1,
Wesche et al., 1997b). MyD88 is therefore a functionalIL-1 receptor (IL-1R), and IL-1R accessory protein (IL-
homolog of Tube, although these two molecules are not1R-AcP). This is followed by the recruitment of IL-1 re-
structurally related. To know the in vivo functional roleceptor±associated kinase (IRAK) to the receptor com-
of MyD88 in IL-1 as well as IL-18 signaling, we haveplex (Greenfeder et al., 1995; Cao et al., 1996a; Huang
generated MyD88-deficient mice. In MyD88-deficientet al., 1997; Korherr et al., 1997; Wesche et al., 1997a).
mice, all of the IL-1- and IL-18-mediated functions exam-Then, IRAK leaves the receptor complex and interacts
ined were impaired, demonstrating that MyD88 is a func-with TRAF6, which finally results in NF-kB activation
tional molecule critical for IL-1- and IL-18-mediated sig-(Cao et al., 1996b). IL-18, originally identified as an inter-
naling.feron-g (IFNg)-inducing factor, promotes the production
of IFNg and enhances natural killercell activity (Okamura
et al., 1995a, 1995b). IL-18 synergizes with IL-12 in in- Results and Discussion
ducing IFNg production from T cells and plays an impor-
tant role in Th1 response (Robinson et al., 1997; Takeda Generation of MyD88-Deficient Mice
The mouse MyD88 gene was disrupted by homologous
recombination in E14.1 embryonic stem (ES) cells. A‖ To whom correspondence should be addressed (e-mail: akira@
hyo-med.ac.jp). targeting vector was designed to replace two exons
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Figure 1. Targeted Disruption of the Mouse
MyD88 Gene
(A) Maps of the MyD88 wild-type genome,
targeting vector, and predicted targeted
gene. Open and closed boxes denote the
noncoding and coding exons, respectively.
Restriction enzymes: B, BamHI; P, PstI.
(B) Southern blot analysis of offspring from
the heterozygote intercrosses. Genomic DNA
was extracted from mouse tails, digested
with BamHI, electrophoresed, and hybridized
with the probe indicated in (A). The approxi-
mate size of the wild-type band is 4.3 kb, and
the mutated band is 1.9 kb.
(C) Northern blot analysis of liver cells. Total
RNA was extracted from liver, electropho-
resed, transferred to nylon membrane, and
hybridized with the mouse MyD88 cDNA
probe. The same membrane was rehybrid-
ized with a b-actin probe.
encoding the C-terminal portion of MyD88 with the neo- growth signal was specifically impaired in the lympho-
cytes from MyD882/2 mice (Figure 2).mycin resistance gene (Figure 1A). This region of the
IL-1 is also shown to induce production of acute phaseMyD88 gene shows high similarity with the cytoplasmic
proteins and inflammatory cytokines such as TNF-a anddomain of the IL-1R. The corresponding region in the
IL-6. We next analyzed the effect of MyD88 deficiencyhuman IL-1R includes the residues critical for its signal-
on these functions. Mice were intravenously injecteding (Hultmark, 1994; Hardiman et al., 1996; Bonnert et
with 1 mg of IL-1b, and 2 hr later liver and sera wereal., 1997). Homologous recombination was achieved in
taken. Total RNA was extracted from the liver and sub-33 out of 176 ES cell clones doubly resistant to G418
jected to Northern blot analysis for expression of serumand gancyclovir. Three targeted ES cell clones were
amyloid A (SAA-I), serum amyloid P (SAP), and haptoglo-microinjected into C57BL/6 blastocysts, two of which
bin (HP). In wild-type mice, there was a dramatic in-successfully transmitted the disrupted MyD88 gene
crease in mRNA expression for SAA-I, SAP, and HPthrough the germline (Figure 1B). MyD88-deficient
after IL-1b injection (Figure 3A). However, IL-1-induced(MyD882/2) mice were born at the expected Mendelian
increase in mRNA expression of SAA-I, SAP, or HP wasratios (1/1: 1/2: 2/2 5 52: 93: 53). The mice grew
not observed in MyD882/2 mice. Serum concentrationshealthy and showed no obvious abnormalities until 20
of TNF-a and IL-6 were measured by enzyme-linkedweeks of age. We performed Northern blot analysis to
immunosorbent assay (ELISA). Serum TNF-a and IL-6confirm that the mutation causes inactivation of the
concentrations were significantly increased after IL-1bMyD88 gene. MyD88 mRNA could not be detected in
injection in wild-type mice (Figure 3B). In contrast, nei-the liver and spleen of MyD882/2 mice (Figure 1C). Flow
ther serum TNF-a nor IL-6 level was elevated after IL-cytometric analysis of the expression of CD3, B220,
1b treatment in MyD882/2 mice. Thus, IL-1-mediatedCD4, and CD8 in thymus, spleen, and lymph node
showed that lymphocyte composition was not altered




We first examined IL-1-mediated response in the mice.
IL-1 is shown to be a costimulant for T cell growth (Man-
nel et al., 1985; Dinarello, 1989; Suda et al., 1989). Thy-
mocytes of MyD882/2 mice and their wild-type littermate
controls were cultured with IL-1b plus several stimuli.
In wild-type mice, thymocytes displayed enhanced pro-
liferation when cultured with phytohemagglutinin (PHA),
concanavalin A (ConA), or a low concentration of IL-2
Figure 2. Impaired IL-1-Mediated T Cell Proliferation in MyD882/2in the presence of IL-1b. However, MyD882/2 thymo-
Micecytes did not show any enhanced proliferation in re-
Thymocytes from wild-type and MyD882/2 mice were incubated withsponse to IL-1b (Figure 2). Similarly, splenocytes from
100 U/ml IL-1b in the presence of the indicated mitogens for 72 hr.MyD882/2 mice did not proliferate in response to IL-1b
[3H]thymidine was pulsed for the last 12 hr, and [3H] uptake was(data not shown). Thymocytes from wild-type and
measured. Thymocytes were also incubated with 20 ng/ml IL-2 in
MyD882/2 mice showed almost equal proliferative re- the presence of 10 ng/ml PMA or 2.5 mg/ml ConA for 72 hr. [3H]
sponse to IL-2 plus Phorbol 12-Myristate 13-Acetate uptake was measured. Representative from three independent ex-
periments.PMA or IL-2 plus ConA, indicating that IL-1-mediated
Loss of IL-1 and IL-18 Signaling in MyD88 KO Mice
145
Figure 3. Impaired IL-1-Induced Expression
of Acute Phase Proteins and Production of
Inflammatory Cytokines in MyD882/2 Mice
(A) Mice were intravenously injected with
IL-1b. Total RNA was extracted from liver
after 2 hr of injection and subjected to North-
ern blot analysis using probes for acute phase
proteins such as SAA-I, SAP, and HP. The
figure is the representative of results from
three independent experiments.
(B) Micewere intravenously injected with 1 mg
of IL-1b. Sera were taken 2 hr after injection.
Concentration of TNF-a and IL-6 was mea-
sured by ELISA. The data are mean 6 S.D.
of six serum samples. N.D., not detected.
major biological functions were severely impaired in activity in MyD882/2 mice. Stimulation of splenocytes
with IL-2 led to almost equal augmentation of the NKMyD882/2 mice.
lytic activity against YAC-1 cells in both wild-type and
MyD882/2 mice, indicating that IL-18-mediated activa-Impaired IL-18-Mediated Functions
tion of NK cells was specifically disturbed in MyD882/2in MyD882/2 Mice
mice (Figure 4A). Besides the activation of NK cells, inIL-18, originally identified as an IFNg-inducing factor,
vitro stimulation of splenocytes with IL-18 induced IFNghas a structural similarity to IL-1, and the receptor for
production in wild-type mice (Figure 4B). In contrast,IL-18 belongs to the IL-1R family (Okamura et al., 1995a,
IFNg production in response to IL-18 was not observed1995b; Bazan et al., 1996; Parnet et al., 1996; Torigoe
in MyD882/2 mice (Figure 4B). Whenwild-type mice wereet al., 1997). Therefore, we examined IL-18-mediated
treated with anti-asialo GM1 antibody, which reducesbiological functions in MyD882/2 mice. IL-18 has been
NK cell population in vivo, splenocytes did not produceshown to be a potent activator of natural killer (NK) cells
IFNg in response to IL-18 (data not shown). These data(Okamura et al., 1995a, 1995b; Tsutsui et al., 1996; Ushio
suggest that NK cells in MyD882/2 mice have a defectet al., 1996). Splenocytes were cultured in the presence
in their capacity to promote IFNg production in responseor absence of IL-18 for 24 hr, and NK lytic activity was
to IL-18.analyzed by 51Cr release from YAC-1 target cells. In vitro
Additionally, IL-18 has been recently shown not toculture of splenocytes with IL-18 dramatically enhanced
drive Th1 development but to potentiate IL-12-inducedthe lytic activity against YAC-1 cells in wild-type mice
Th1 development (Matsui et al., 1997; Robinson et al.,(Figure 4A). However, IL-18 did not enhance NK lytic
1997; Takeda et al., 1998). Naive splenic T cells were
cultured with IL-12 on anti-CD3 antibody-coated plates
to induce Th1 cell development. After 4 days of culture,
these Th1-developing cells were washed and restimu-
lated with IL-18 or IL-12 on anti-CD3 antibody-coated
plates for 24 hr. Culture supernatants were analyzed for
IFNg production by ELISA. Both wild-type and MyD882/2
T cells produced almost equal levels of IFNg by stimu-
lation with anti-CD3 antibody, indicating that IL-12-
induced Th1 cell development in vitro was not impaired
in MyD882/2 mice. T cells from wild-type mice produced
an elevated level of IFNg in response to IL-18 (Figure
5A). In contrast, T cells from MyD882/2 mice did not
show any enhanced production of IFNg in response to
IL-18.
It has been shown that IL-18-deficient mice displayed
defective Th1 cell development after injection of Propi-
onibacterium acnes (P. acnes) and Bacillus Calmette-
GueÂ rin (BCG) (Takeda et al., 1998). MyD882/2 mice were
injected with heat-killed P. acnes, and 7 days later
splenic T cells were purified and stimulated with immobi-
lized anti-CD3 antibody in the presence or absence of
Figure 4. Impaired IL-18-Mediated NK Cell Activation in MyD882/2 IL-18. Wild-type T cells produced significant levels of
Mice IFNg, and the presence of IL-18 resulted in enhanced
(A) Splenocytes from wild-type and MyD882/2 mice were cultured production of IFNg. In contrast, IFNg production from
in the presence of IL-18 or IL-2 for 24 hr. NK lytic activity against MyD882/2 T cells was severely reduced when compared
YAC-1 target cells was analyzed. Representative results from three
with wild-type. In addition, increased IFNg productionindependent experiments.
in response to IL-18 was not observed in MyD882/2 T(B) Splenocytes were cultured with or without 20 ng/ml IL-18 for 24
cells (Figure 5B). T cells of BCG-infected wild-type micehr. Concentration of IFNg in the culture supernatants was measured
by ELISA. N.D., not detected. also produced high amounts of IFNg and more enhanced
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the case with IL-18-deficient mice. Thus, major biologi-
cal activities mediated by IL-18 were completely abol-
ished in MyD882/2 mice.
Dominant Negative MyD88 Blocks IL-18-Induced
Activation of NF-kB and AP-1
MyD882/2 mice displayed severely impaired IL-18-medi-
ated functions. Therefore, we examined whether the IL-
18R complex interacts with MyD88 as shown in the case
of the IL-1R complex (Muzio et al., 1997; Wesche et
al., 1997b). We transiently coexpressed FLAG-tagged
MyD88 and Myc-tagged IL-18R into COS-7 cells. The
cell lysates were immunoprecipitated with the anti-Myc
antibody and blotted with the anti-FLAG antibody.
FLAG-tagged MyD88 was coimmunoprecipitated with
the anti-Myc antibody (Figure 6A). Reciprocally, Myc-
tagged IL-18R was also coimmunoprecipitated with the
anti-FLAG antibody. Thus, MyD88 specifically associ-
ates with IL-18R.
The C-terminal domain of MyD88 (amino acids 152 to
296) has been shown to act as a dominant negative
inhibitor of IL-1R complex±induced NF-kB activation
(Muzio et al., 1997; Wesche et al., 1997b). In addition,Figure 5. Impaired IL-18-Mediated Th1 Response in MyD882/2 Mice
IL-18 is shown to induce NF-kB activation as does IL-1(A) Splenic T cells were purified and incubated with or without 2 ng/
(Matsumoto et al., 1997; Robinson et al., 1997). There-ml IL-12 on anti-CD3 Ab-coated plates. After 4 days of culture, T
fore, we studied whether the dominant negative MyD88cells were washed and restimulated with 20 ng/ml IL-18 and/or 2
ng/ml IL-12 on anti-CD3 Ab-coated plates for 24 hr. Production of mutant blocks IL-18-induced NF-kB activation as well.
IFNg from T cells was analyzed by ELISA. COS-7 cells were transiently transfected with MyD88
(B) Mice were intraperitoneally injected with 500 mg of heat-killed (152±296) expression vector together with NF-kB-depen-
P. acnes. Seven days after injection, splenic T cells were purified dent luciferase reporter gene, and luciferase activity
and stimulated with immobilized anti-CD3 antibody in the presence
after IL-18 treatment was measured. Coexpression ofor absence of 20 ng/ml IL-18 for 24 hr. The concentration of IFNg
MyD88 (152±296) almost completely blocked IL-18-in culture supernatants was measured by ELISA. In the case of
induced NF-kB activation (Figure 6B, upper). IL-18 isBCG infection, mice were intravenously injected with 2 mg of BCG.
also shown to activate AP-1-dependent gene expres-Production of IFNg from splenic T cells was analyzed by ELISA 14
days later. sion (Barbulescu et al., 1998). We examined whether
MyD88 (152±296) also acts as a dominant negative mu-
tant of IL-18-induced AP-1 activation. Stimulation with
levels of IFNg in response to IL-18. However, IFNg pro- IL-18 induced an approximately 3- to 4-fold increase in
duction from T cells of BCG-infected MyD882/2 mice AP-1 activity, and this activation was blocked by coex-
was about 3-fold lower than that from wild-type T cells pression of MyD88 (152±296) (Figure 6B, lower). Taken
(Figure 5B). These results demonstrate that MyD882/2 together, these results show that MyD88 is involved in
IL-18-induced activation of both NF-kB and AP-1.mice are defective in Th1 cell development in vivo as is
Figure 6. MyD88 Interacts with IL-18 Recep-
tor and Induces NF-kB and AP-1 Activation
(A) COS-7 cells were transiently cotrans-
fected with the indicated combination of ex-
pression vectors for FLAG-tagged MyD88,
Myc-tagged IL-18R, or empty vector (Vector).
After 36 hr, cell lysates were prepared and
immunoprecipitated with either anti-Myc an-
tibody or anti-FLAG antibody. Coprecipitat-
ing FLAG-MyD88 or Myc-IL-18R protein was
detected by Western blotting with either anti-
FLAG antibody or anti-Myc antibody, respec-
tively. The total level of protein expression
was monitored by Western blot analysis of
the same lysates with the relevant antibodies.
The molecular weight (in kilodaltons) is listed
on the left.
(B) COS-7 cells were transiently cotrans-
fected with pNF-kB-Luc or pAP-1-Luc re-
porter gene plasmid together with expression
plasmid for IL-18R or MyD88 (152±296) as
indicated. Cells were left untreated (open bars) or stimulated with 1.0 mg/ml IL-18 (closed bars) 24 hr after transfection. After 3 hr, relative
luciferase activity was determined. Similar results were obtained from three independent experiments.
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Th1-developing cells of wild-type mice. However, IL-18-
induced JNK activation was not observed in MyD882/2
cells. Bycontrast, normal activaion of JNK was observed
in MyD882/2 cells treated with TNF-a. Thus, IL-18-
induced NF-kB and JNK activation was abrogated in
MyD882/2 mice, although TNF-a-induced activation was
not affected. Taken together, these results demonstrate
that MyD88 is essential for IL-18-induced activation of
both NF-kB and JNK.
In the present study, we demonstrated that MyD88 is
essential for IL-1 and IL-18 signaling, because the major
functions mediated by these cytokines were almost
completely abolished in the MyD882/2 mice. The family
of IL-1R/Toll related proteins is now expanding in mam-
mals (Medzhitov and Janeway, 1997; Medzhitov et al.,
1997). These include IL-1R-related protein (IL-1Rrp), IL-
1Rrp2, T1/ST2, and recently identified human Toll-like
molecules (TLR1-5) (Yanagisawa et al., 1993; Lovenberg
et al., 1996; Mitcham et al., 1996; Parnet et al., 1996;
Rock et al., 1998). Recently, IL-1Rrp was found to be
the receptor for IL-18 (Torigoe et al, 1997). The ligands
Figure 7. Loss of NF-kB and JNK Activation in Response to IL-18 and biological functions of several IL-1R-related mole-
in MyD882/2 Cells cules have yet to be clarified. MyD88 may also parti-
(A) T cells cultured with IL-12 plus anti-CD3 antibody for 4 days cipate in the signaling of these orphan receptors such
were stimulated with 100 ng/ml IL-18 for 30 min, and thymocytes as IL-1Rrp2, T1/ST2, and TLR1-5. Thus, the use of
were stimulated with 100 ng/ml TNF-a for 30 min. Nuclear extracts
MyD882/2 mice may help to elucidate the functions ofwere then prepared and incubated with a specific probe containing
these orphan receptors. In this respect, it is noteworthyNF-kB-binding sites, and NF-kB activity was determined by a gel
that MyD882/2 mice are viable when we consider thatmobility shift assay. Specificity was determined by adding none (N),
50-fold molar excess of specific competitor (C), or 1.0 mg of specific the Toll pathway in Drosophila is analogous to the IL-1
antibody to p65 (Ab). Inducible NF-kB complex was indicated by pathway in mammals and that MyD88 is a functional
the arrow. The asterisks show the supershift. The free probe was mammalian homolog of Drosophila Tube, whose loss
indicated by the arrow head.
of function results in early embryonic lethality due to(B) Cells (Th1-developing cells used for IL-18 stimulation and thymo-
defective dorsoventral polarity in Drosophila (Letsou etcytes for TNF-a) were left untreated or stimulated with 100 ng/ml
al., 1993; Belvin and Anderson, 1996; Norris and Manley,IL-18 or 100 ng/ml TNF-a for 20 min. Cell lysates were prepared
and immunoprecipitated with anti-JNK antibody. The kinase activity 1996). Based on these findings, mammalian Toll-like
was measured using GST-c-Jun-fusion protein as a substrate (up- molecules appear to utilize another Tube-related mole-
per). The lower panels show Western blot analysis of the same cule or do not play a major role in mammalian develop-
lysates with anti-JNK antibody.
ment. Future studies will be required to answer this
question. Finally, agents that block the function of
Loss of IL-18-Induced NF-kB DNA Binding Activity MyD88 will be therapeutically useful against a variety
and JNK Activation in MyD882/2 of pathological conditions associated with excessive
Th1-Developing Cells production of the IL-1 family of cytokines.
We next investigated whether IL-18-induced activation
of NF-kB was observed in MyD882/2 cells. Splenic T Experimental Procedures
cells cultured with IL-12 plus anti-CD3 antibody for 4
Generation of MyD882/2 Micedays were starved for 3 hr and then stimulated with
The MyD88 genomic DNA was screened from a 129/SvJ mouseIL-18. Nuclear extracts from the stimulated cells were
genomic library (Stratagene), subcloned into pBluescript vectoranalyzed by a gel mobility shift assay using a specific
(Stratagene), and characterized by restriction enzyme mapping and
probe containing NF-kB binding site. As shown in Figure DNA sequencing. A targeting vector was constructed to replace the
7A, IL-18-induced NF-kB DNA binding activity was de- 1.0 kb genomic fragment with the neomycin resistance gene from
pMC1-neo (Stratagene). The replaced genomic fragment containedtected in the nuclear extracts from wild-type cells but
2 exons encoding the domain that resembles the cytoplasmic do-not from MyD882/2 cells. On the other hand, treatment
main of the IL-1RAcP. The neomycin resistance gene was flankedof wild-type or MyD882/2 thymocytes with TNF-a re-
by the 1.1 kb 59 genomic fragment and the 5.2 kb 39 fragment.sulted in almost the same levels of NF-kB DNA binding
An HSV-tk cassette was introduced at the 39 end of the genomic
activity, demonstrating that the impaired IL-18-induced fragment. E14.1 ES cells were transfected with the linearized tar-
NF-kB activation in MyD882/2 cells was not due to the geting vector and selected with G418 and gancyclovir. Doubly resis-
tant clones were screened for homologous recombination by PCRabnormal function or down-regulation of NF-kB.
and verified by Southern blot analysis using the probe indicated inIn addition to induction of NF-kB activation, IL-1 is
Figure 1A. Three independently identified targeted ES clones werealso shown to activate c-Jun N-terminal kinase (JNK)
microinjected into the blastocysts of C57BL/6 mice. Chimeric mice(Wesche et al., 1997a). To test whether IL-18 induces
were mated with C57BL/6 female mice to produce heterozygous
JNK activation, we carried out an in vitro kinase assay mice. Heterozygous mice were intercrossed to obtain homozygotes.
using GST-c-Jun-fusion protein as a substrate (Figure MyD882/2 mice and their wild-type littermates from these inter-
crosses were used for experiments.7B). Treatment with IL-18 induced JNK activation in
Immunity
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T Cell Proliferation Assay pEF-BOS (Mizushima and Nagata, 1990). The C-terminal Myc-
tagged human IL-18R cDNA was obtained by PCR from human IL-Thymocytes (1 3 105) were cultured in 96-well plates for 72 hr with
100 U/ml IL-1b (Genzyme) in the presence of 2 mg/ml PHA, 2.5 mg/ml 18R cDNA as a template and ligated into pEF-BOS. Human IL-18R
cDNA was kindly provided by Hayashibara Biochemical Labora-ConA, or 2 ng/ml IL-2. [3H]thymidine was pulsed for the last 12 hr,
and [3H] uptake was measured. In the case of the response to IL-2, tories, Inc.
thymocytes were cultured with 20 ng/ml IL-2 (Genzyme) in the pres-
ence of 10 ng/ml PMA or 2.5 mg/ml ConA. Reporter Assay
COS-7 cells (1 3 105) seeded on 6-well plates were transiently co-
transfected with 1.0 mg of reporter plasmid (pNF-kB Luc or pAP-1Induction of Inflammatory Cytokines and Acute
Luc) (Stratagene) together with expression plasmids for IL-18R (0.4Phase Proteins
mg) and MyD88 (152±296) (0.6 mg) by Lipofection. The total amountsMice were intravenously injected with 1 mg of recombinant mouse
of DNA were kept constant by supplementation with empty vectorIL-1b (Genzyme). After 2 hr of injection, mice were bled for serum
(pEF-BOS). After 24 hr of transfection, cells were stimulated with 1cytokine and sacrificed. Total RNAwas extracted from the liver using
mg/ml of recombinant human IL-18 for 3 hr. The relative NF-kB orthe TRIZOL reagent (GIBCO). RNA (10 mg) was electrophoresed,
AP-1 activity was determined and normalized on the basis of sea-transferred to a nylon membrane, and hybridized with 32P-labeled
pansy luciferase activity (pRL-SV40) (Promega). The recombinantcDNA probes for SAA-I, SAP, and HP. Serum concentrations of
human IL-18 was kindly provided by Hayashibara BiochemicalLabo-TNF-a and IL-6 were determined by ELISA (Genzyme).
ratories, Inc.
Analysis of NK Cell Activity Gel Mobility Shift Assay
Splenocytes were cultured for 24 hr with or without 20 ng/ml IL-18 Splenic T cells were purified and cultured with 2 ng/ml IL-12 plus
or 100 U/ml IL-2. Then, cultured cells were incubated with 51Cr- 100 ng/ml anti-CD3 antibody. After 4 days of culture, T cells were
labeled YAC-1 target cells at the indicated effector/target ratios. washed and starved with RPMI 1640 containing 2% FCS for 3 hr.
After 4 hr of incubation, supernatants were counted for 51Cr release Cells (1 3 107) were stimulated with 100 ng/ml IL-18 for 30 min.
using a gamma counter. IL-18 was kindly provided by Hayashibara In the case of TNF-a-induced NF-kB activation, freshly isolated
Biochemical Laboratories, Inc. (Japan). thymocytes (1 3 107) were stimulated with 100 ng/ml TNF-a for 30
min. Cells were washed once with phosphate-buffered saline and
resuspended in 400 ml of buffer A (10 mM HEPES [pH 7.8], 10 mMInduction of Th1 Cell Differentiation
KCl, 0.1 mM EDTA, 1 mM DTT, 2 mg/ml Aprotinin, 0.5 mM PMSF,Splenic T cells were purified as described previously (Takeda et al.,
and 0.5% Triton X-100). Nuclei were pelleted, and the cytoplasmic1998). In brief, splenic T cells were enriched by two rounds of nylon
proteins were carefully removed. The nuclei were then resuspendedwool column passage. Enriched T cells were incubated with anti-I-
in buffer C (50 mM HEPES [pH 7.8], 420 mM KCl, 0.1 mM EDTA, 5Ab antibody for 30 min on ice and then washed and incubated with
mM MgCl2, 10% Glycerol, 1 mM DTT, 2 mg/ml Aprotinin, and 0.5rabbit complement (Low-Tox-M, Cedar Lane) for 45 min at 378C.
mM PMSF). After vortexing andstirring for 30min at48C, the samplesCell purity was analyzed by flow cytometry using fluorescein isothi-
were centrifuged, and the nuclear proteins in the supernatant werecyanate±conjugated anti-CD3 antibody (PharMingen). T cells puri-
transferred to a fresh vial. Protein concentration of nuclear extractsfied to more than 95% were cultured on anti-CD3 Ab (20 mg/ml)-
was determined by BCA Protein Assay Reagent (Pierce). Double-coated plates in the presence of 2 ng/ml IL-12. After the 4 days of
stranded, NF-kB-specific oligonucleotide probe containing two tan-culture, cells were harvested and washed with Hanks' balanced salt
demly positioned NF-kB-binding sites (59-ATCAGGGACTTTCCGCTsolution. Cells (2 3 105) were stimulated on anti-CD3 Ab (20 mg/ml)-
GGGGACTTTCCG-39 and 59-GGCGGAAAGTCCCCAGCGGAAAGTCcoated 96-well plates for 24 hr in the presence or absence of 20
CCTGAT-39) were labeled with [a-32P]dCTP by Klenow fragment.ng/ml IL-18 and/or 2 ng/ml IL-12. Concentration of IFNg in culture
Nuclear extract (3 mg) was incubated with a 300 fmol probe in asupernatants was determined by ELISA (Genzyme).
total of 25 ml of binding buffer (10 mM HEPES [pH 7.8], 50 mM KCl,In the case of in vivo induction of Th1 cell development, mice
1 mM EDTA, 5 mM MgCl2, 10% glycerol, and 2 mg of poly-dIdC) forwere intraperitoneally injected with 500 mg of heat-killed P. acnes.
20 min at room temperature. For the competition assay, a 50-foldSeven days after injection, T cells were purified from spleen and
molar excess of unlabeled oligonucleotide probe was added to nu-stimulated on anti-CD3 Ab (20 mg/ml)-coated 96-well plates for 24
clear extracts for 15 min before addition of the labeled probe. Thehr in the presence or absence of 20 ng/ml IL-18. For BCG treatment,
supershift assay was performed by preincubating with 1 mg of anti-mice were intravenouslly injected with 2 mg of BCG (Kyowa, Japan).
p65 antibody (Santa Cruz) for 60 min at 48C before addition of theT cells were purified and assayed for IFNg production, as described
labeled probe. After incubation, samples were fractionated on a 4%above, 14 days after injection.
polyacrylamide gel in 25 mM Tris-Cl (pH 8.5), 190 mM glycine, and
1 mM EDTA. The gel was subsequently dried and visualized by
Transfection, Immunoprecipitation, and Western Blot Analysis autoadiography.
COS-7 cells (1 3 106) were transiently cotransfected with a total of
10 mg of the indicated plasmids by Lipofection according to the In Vitro Kinase Assay
manufacturer's instructions (Mirus Corporation). After 36 hr, cells Th1-developing cells prepared as described above (5 3 106) were
were lysed in 500 ml of lysis buffer containing 0.5% Nonidet P-40, stimulated with 100 ng/ml IL-18 for 20 min. Freshly isolated thymo-
150 mM NaCl, 1 mM EDTA, and 10 mM Tris-HCl (pH 7.2). Half cytes (5 3 106) were stimulated with 100 ng/ml TNF-a for 20 min.
of the cell lysate was incubated with 2 mg of anti-FLAG antibody Cells were then lysed in an ice-cold lysis buffer (20 mM Tris-Cl [pH
(Eastman Kodak Company) and 40 ml of protein-G Sepharose (Phar- 8.0], 137 mM NaCl, 5 mM EDTA, 10% glycerol, 1% Triton X-100, 1
macia) for 12 hr at 48C, and the other half was incubated with 2 mg
mM PMSF, 20 mg/ml Aprotinin, 20 mg/ml Leupeptin, 1 mM Na3VO4,of anti-Myc antibody (Santa Cruz) and 40 ml of protein-A Sepharose
1 mM EGTA, 10 mM NaF, 1 mM Na4P2O7, and 10 mM b-glycerophos-(Pharmacia). After washingwith the lysis buffer, the immunocomplex
phate). Cell lysates were precleared for 1 hr with protein A-Sepha-
was eluted by boiling in SDS-PAGE sample buffer, separated on
rose and then mixed with 0.5 mg of rabbit anti-JNK1 antibody (Santa
SDS-PAGE, and transferred onto a nitrocellulose filter. The filter was
Cruz) and protein A-Sepharose for 12 hr. The beads were washed
blotted with either the anti-FLAG antibody or the anti-Myc antibody
four times with the lysis buffer and once with the kinase assay buffer
and visualized using the enhanced chemiluminescence system (25 mM HEPES [pH 7.6], 20 mM MgCl2, 20 mM b-glycerophosphate,(Dupont). 1 mM Na3VO4, and 2 mM DTT). Kinase reactions were carried out
in 20 ml of the kinase buffer containing 1 mg of GST-c-Jun (1±79)-
fusion protein (Santa Cruz) and 10 mCi [g-32P] ATP for 30 min atExpression Plasmids
The C-terminal FLAG-tagged human MyD88 and MyD88 (152±296) 308C. Reactions were terminated by adding 20 ml of 23 SDS-PAGE
sample buffer. Proteins were separated on SDS-PAGE and visual-(amino acid 152 to 296) cDNAs were obtained by PCR from a human
placenta cDNA library and ligated into mammalian expressionvector ized by autoradiography.
Loss of IL-1 and IL-18 Signaling in MyD88 KO Mice
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